Daniel C. Maneval
- Biotechnology top 0.5%
- Cancer Research and Treatments 21
- Oncology top 1%
- HER2/EGFR in Cancer Research 9
- Genetics top 2%
- Virus-based gene therapy research 23
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 7
-
- Monoclonal and Polyclonal Antibodies Research 7
-
- Proteoglycans and glycosaminoglycans research 24
-
- Fibroblast Growth Factor Research 17
- Glycosylation and Glycoproteins Research 7
- Co-authors
- Loretta L. NielsenH. Michael ShepardDennis J. SlamonPing JiangG. J. FrostCurtis B. ThompsonKen N. WillsRichard J. Gregory
- Cited by
- BiotechnologyOncologyGenetics
- Journals
- Cancer Research (8 papers)Journal of Clinical Oncology (6 papers)Cancer Gene Therapy (4 papers)
- Partner nations
- United StatesJapanGermany
In The Last Decade
Daniel C. Maneval
72 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Biotechnology 660
- Oncology 1.9k
- Genetics 938
- Cancer Research 387
- Radiology, Nuclear Medicine and Imaging 547
Countries citing papers authored by Daniel C. Maneval
This map shows the geographic impact of Daniel C. Maneval's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel C. Maneval with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel C. Maneval more than expected).
Fields of papers citing papers by Daniel C. Maneval
This network shows the impact of papers produced by Daniel C. Maneval. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel C. Maneval. The network helps show where Daniel C. Maneval may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Daniel C. Maneval, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 8 | |
| 3 | 2023 | 5 | |
| 4 | 2021 | 3 | |
| 5 | 2020 | 17 | |
| 6 | 2019 | 115 | |
| 7 | 2019 | 18 | |
| 8 | 2018 | 69 | |
| 9 | 2017 | 4 | |
| 10 | Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancerbreakdown → | 2012 | 837 |
| 11 | 2011 | 1 | |
| 12 | 2011 | 88 | |
| 13 | 2007 | 20 | |
| 14 | 2005 | 40 | |
| 15 | Preventing Posterior Capsule Opacification Using a Recombinant Adenovirus-Encoded p21WAF1/CIP1 Transgene | 2003 | 1 |
| 16 | 2002 | 36 | |
| 17 | 2000 | 7 | |
| 18 | p53 gene therapy in vivo of herpatocellular and liver metastatic colorectal cancer. | 1996 | 35 |
| 19 | 1995 | 21 | |
| 20 | Radiolabeled antibody targeting of the HER-2/neu oncoprotein. | 1992 | 98 |
About Daniel C. Maneval
Daniel C. Maneval is a scholar working on Biotechnology, Cell Biology, Oncology, Genetics and Radiation, having authored 75 papers that have together received 3.5k indexed citations. Recurring topics across this work include Proteoglycans and glycosaminoglycans research (24 papers), Virus-based gene therapy research (23 papers), Cancer Research and Treatments (21 papers), Fibroblast Growth Factor Research (17 papers), HER2/EGFR in Cancer Research (9 papers), Glycosylation and Glycoproteins Research (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Cancer, Hypoxia, and Metabolism (7 papers). The work is most often cited by research in Biotechnology (660 citations), Oncology (1.9k citations), Genetics (938 citations), Cancer Research (387 citations) and Radiology, Nuclear Medicine and Imaging (547 citations). Daniel C. Maneval has collaborated with scholars based in United States, Japan and Germany. Frequent co-authors include Loretta L. Nielsen, H. Michael Shepard, H. Michael Shepard, Dennis J. Slamon, Ping Jiang, G. J. Frost, Curtis B. Thompson, Ken N. Wills, Richard J. Gregory and Michael J. LaBarre. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Cancer Gene Therapy, ESMO Open and Physics in Medicine and Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.